• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜炎对腹膜透析患者血浆及透析液中α1-酸性糖蛋白浓度的影响。

Effect of peritonitis on plasma and dialysate alpha 1-acid glycoprotein concentrations in peritoneal dialysis patients.

作者信息

Bohenek W S, Johnson C A, Ateshkadi A, Oxton L L, Zimmerman S W

机构信息

Department of Pharmaceutical Services, University of Chicago Hospitals, IL.

出版信息

Clin Pharm. 1993 Aug;12(8):602-5.

PMID:8222525
Abstract

The effect of peritonitis on plasma and dialysate alpha 1-acid glycoprotein (AAG) concentrations was determined. Plasma and dialysate samples were obtained at the onset of infection and one month after treatment from 10 peritoneal dialysis patients with peritonitis. Plasma and dialysate samples were also obtained from 10 noninfected matched controls. Sampling was repeated after a minimum of one month. Samples were assayed for AAG by radial immunodiffusion. The mean +/- S.D. plasma AAG concentrations for patients with peritonitis and for control patients were 152.4 +/- 30.9 mg/dL and 146.6 +/- 45.0 mg/dL, respectively (p > 0.05). The dialysate AAG concentrations for nine control patients were below the limit of detection. The mean +/- S.D. dialysate concentration for the nine infected patients with detectable AAG concentrations was 15.4 +/- 9.5 mg/dL. After successful antimicrobial therapy, dialysate AAG concentrations declined. There was no obvious correlation between dialysate white blood cell count and dialysate AAG concentration during peritonitis. Peritonitis increased dialysate AAG concentrations but had no effect on plasma AAG concentrations.

摘要

测定了腹膜炎对血浆和透析液中α1-酸性糖蛋白(AAG)浓度的影响。从10例患有腹膜炎的腹膜透析患者身上,在感染发作时和治疗后1个月采集血浆和透析液样本。还从10名匹配的未感染对照者身上采集血浆和透析液样本。至少1个月后重复采样。通过放射免疫扩散法测定样本中的AAG。腹膜炎患者和对照患者的血浆AAG平均浓度±标准差分别为152.4±30.9mg/dL和146.6±45.0mg/dL(p>0.05)。9名对照患者的透析液AAG浓度低于检测限。9名AAG浓度可检测的感染患者的透析液平均浓度±标准差为15.4±9.5mg/dL。成功的抗菌治疗后,透析液AAG浓度下降。腹膜炎期间,透析液白细胞计数与透析液AAG浓度之间无明显相关性。腹膜炎会增加透析液AAG浓度,但对血浆AAG浓度无影响。

相似文献

1
Effect of peritonitis on plasma and dialysate alpha 1-acid glycoprotein concentrations in peritoneal dialysis patients.腹膜炎对腹膜透析患者血浆及透析液中α1-酸性糖蛋白浓度的影响。
Clin Pharm. 1993 Aug;12(8):602-5.
2
Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.一氧化氮是持续非卧床腹膜透析患者腹膜炎的一个标志物。
Adv Perit Dial. 1998;14:173-9.
3
Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.腹膜炎、腹膜炎症与膜通透性:腹膜透析稳定患者透析液和血清MCP-1的纵向研究
J Nephrol. 2007 May-Jun;20(3):340-9.
4
Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.透析液细胞计数在并发于腹膜透析的腹膜炎中的预测价值。
Clin J Am Soc Nephrol. 2006 Jul;1(4):768-73. doi: 10.2215/CJN.01010306. Epub 2006 May 31.
5
Elevated plasma alpha 1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy.血浆α1-酸性糖蛋白水平升高:与抗惊厥治疗诱导的维库溴铵阻滞抵抗缺乏关联。
J Neurosurg Anesthesiol. 1997 Jan;9(1):3-7.
6
Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.克林霉素在α1-酸性糖蛋白浓度正常和升高的血清中的体外蛋白结合情况。
Pharmacotherapy. 1992;12(1):50-5.
7
Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis.透析相关性腹膜炎患者腹膜透析液的蛋白质组学分析
Ren Fail. 2008;30(8):772-7. doi: 10.1080/08860220802248969.
8
The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.生物相容性碳酸氢盐腹膜透析液条件下透析液中癌抗原125浓度的变化及间皮细胞活力的维持。
Ren Fail. 2008;30(2):161-7. doi: 10.1080/08860220701808384.
9
[Effect of peritonitis pathomorphology on rabbit model in peritoneal dialysis].[腹膜炎病理形态对兔腹膜透析模型的影响]
Hunan Yi Ke Da Xue Xue Bao. 2001 Jun 28;26(3):203-6.
10
[Tissue factor and tissue factor pathway inhibitor in peritonitis treated with dialysis].[透析治疗腹膜炎中的组织因子与组织因子途径抑制物]
Przegl Lek. 2000;57(7-8):374-7.